Ameriprise
OTIC

Ameriprise’s Otonomy, Inc. OTIC Stock Holding History

Ameriprise’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,600
Closed -$45K – 4062
2022
Q2 		$45K Sell
21,600
-1,000
-4% -$2.08K ﹤0.01% 3832
2022
Q1 		$54K Hold
22,600
– – ﹤0.01% 3875
2021
Q4 		$47K Sell
22,600
-10,900
-33% -$22.4K ﹤0.01% 3904
2021
Q3 		$64K Sell
33,500
-13,800
-29% -$23.4K ﹤0.01% 3805
2021
Q2 		$105K Hold
47,300
– – ﹤0.01% 3824
2021
Q1 		$121K Buy
47,300
+9,600
+25% +$39.3K ﹤0.01% 3756
2020
Q4 		$238K Buy
+37,700
New +$171K ﹤0.01% 3586
2016
Q1 		– Sell
-77,115
Closed -$2.14M – 3902
2015
Q4 		$2.14M Buy
+77,115
New +$1.92M ﹤0.01% 2570

Other funds holding OTIC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Ameriprise's OTIC Position: Q3 2022 in Review

Ameriprise sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 21,600 shares — an estimated $45K sold.

Ameriprise first reported a position in OTIC in Q4 2015 and held it in 8 quarters. The position peaked at $2.14M in Q4 2015. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • Ameriprise reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 21,600 Otonomy, Inc. shares in Q3 2022, an estimated $45K.
  • Ameriprise first reported a position in Otonomy, Inc. in Q4 2015 and held it in 8 quarters.
  • Ameriprise's Otonomy, Inc. position peaked at $2.14M in Q4 2015.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.